FORM 10-K

Company

REGENERON PHARMACEUTICALS, INC.

Filed

February 8, 2018

Period of Report

December 31, 2017

Accession Number

0001532176-18-000013

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →